Mitraclip Followed by Surgical Aortic Valve Replacement: Hybrid Techniques for Regurgitant Aortic and Mitral Valve Disease Kyle Eudailey, MD, Nadira Hamid, MD, Rebecca T. Hahn, MD, Susheel Kodali, MD, William Gray, MD, Isaac George, MD The Annals of Thoracic Surgery Volume 102, Issue 2, Pages e83-e85 (August 2016) DOI: 10.1016/j.athoracsur.2015.12.071 Copyright © 2016 The Society of Thoracic Surgeons Terms and Conditions
Fig 1 Failed surgical aortic bioprosthetic valve with multiple areas of paravalvular leak (red arrows); not suitable for percutaneous closure. The Annals of Thoracic Surgery 2016 102, e83-e85DOI: (10.1016/j.athoracsur.2015.12.071) Copyright © 2016 The Society of Thoracic Surgeons Terms and Conditions
Fig 2 (A, C) Moderate-severe mitral regurgitation secondary to posterior leaflet tethering (green arrow). (B) Three-dimensional planimetry effective regurgitation orifice (EROA). (D) Three-dimensional mitral valve area (MVA) planimetry. The Annals of Thoracic Surgery 2016 102, e83-e85DOI: (10.1016/j.athoracsur.2015.12.071) Copyright © 2016 The Society of Thoracic Surgeons Terms and Conditions
Fig 3 (A) Residual trace mitral regurgitation. (B) Three-dimensional (3D) planimetry of residual mitral valve area (MVA). (C) Total residual 3-dimensional planimetry effective regurgitation orifice (EROA) was 8 mm2. (D) Mean mitral valve gradient (MPG) post MitraClip. (Vmax = maximum velocity; Vmean = mean velocity; PG = peak gradient; VTI = velocity time integral.) The Annals of Thoracic Surgery 2016 102, e83-e85DOI: (10.1016/j.athoracsur.2015.12.071) Copyright © 2016 The Society of Thoracic Surgeons Terms and Conditions